NCT07576179 Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPN
| NCT ID | NCT07576179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Diabetic Peripheral Neuropathy (DPN) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2026-07-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-20 with a primary completion date of 2026-07-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the comparative effects of plantar intrinsic muscles exercises and three-dimensional ankle foot exercises on balance, gait and fall risk in patients with diabetic peripheral neuropathy.
Eligibility Criteria
Inclusion Criteria: * The participants who scored ≥ 7 (abnormal) as per the Michigan Neuropathy Screening Instrument (MNSI) * Able to ambulate 10 m barefoot without using a walking aid * Patient reporting to have either fear of falling or experienced a fall in the previous 12 months * Cognitive Function on Mini-Mental State Examination is normal (MMSE score: Above 25) * Patients having difficulties with mobility, gait, or balance in daily life Exclusion Criteria: * Presence of other neurological conditions (GBS, Paraneoplastic Neuropathy, Infectious Neuropathy, others) * Severe Retinopathy, a vascular complication of DM. * Limited Ankle and foot ROM due to fracture or contracture. * Presence of active plantar ulcers. * Recent surgeries or injuries in the foot/lower limb. * Musculoskeletal disorders affecting gait (Osteoarthritis, Rheumatoid arthritis, Muscular dystrophy, Hip dysplasia, others) * Participation in another rehabilitation or training concurrently
Contact & Investigator
Hira Jabeen, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576179 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying Diabetic Peripheral Neuropathy (DPN). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576179 currently recruiting?
Yes, NCT07576179 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576179 trial being conducted?
This trial is being conducted at Sargodha, Pakistan.
Who is sponsoring the NCT07576179 clinical trial?
NCT07576179 is sponsored by Riphah International University. The principal investigator is Hira Jabeen, MS-PT at Riphah International University. The trial plans to enroll 40 participants.